These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30371745)

  • 41. Regression modeling of the cumulative incidence function with missing causes of failure using pseudo-values.
    Moreno-Betancur M; Latouche A
    Stat Med; 2013 Aug; 32(18):3206-23. PubMed ID: 23653257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive Bayesian inference and dynamic treatment regimes.
    Saarela O; Arjas E; Stephens DA; Moodie EE
    Biom J; 2015 Nov; 57(6):941-58. PubMed ID: 26259996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urn models for response-adaptive randomized designs: a simulation study based on a non-adaptive randomized trial.
    Ghiglietti A; Scarale MG; Miceli R; Ieva F; Mariani L; Gavazzi C; Paganoni AM; Edefonti V
    J Biopharm Stat; 2018; 28(6):1203-1215. PubMed ID: 29565749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SMART designs in cancer research: Past, present, and future.
    Kidwell KM
    Clin Trials; 2014 Aug; 11(4):445-456. PubMed ID: 24733671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Semiparametric competing risks regression under interval censoring using the R package intccr.
    Park J; Bakoyannis G; Yiannoutsos CT
    Comput Methods Programs Biomed; 2019 May; 173():167-176. PubMed ID: 31046992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynamic treatment regimens in small n, sequential, multiple assignment, randomized trials: An application in focal segmental glomerulosclerosis.
    Chao YC; Trachtman H; Gipson DS; Spino C; Braun TM; Kidwell KM
    Contemp Clin Trials; 2020 May; 92():105989. PubMed ID: 32200006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On an enhanced rank-preserving structural failure time model to handle treatment switch, crossover, and dropout.
    Li L; Tang S; Jiang L
    Stat Med; 2017 May; 36(10):1532-1547. PubMed ID: 28110508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multiple imputation strategy for sequential multiple assignment randomized trials.
    Shortreed SM; Laber E; Scott Stroup T; Pineau J; Murphy SA
    Stat Med; 2014 Oct; 33(24):4202-14. PubMed ID: 24919867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct likelihood inference and sensitivity analysis for competing risks regression with missing causes of failure.
    Moreno-Betancur M; Rey G; Latouche A
    Biometrics; 2015 Jun; 71(2):498-507. PubMed ID: 25761785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Semiparametric regression and risk prediction with competing risks data under missing cause of failure.
    Bakoyannis G; Zhang Y; Yiannoutsos CT
    Lifetime Data Anal; 2020 Oct; 26(4):659-684. PubMed ID: 31982977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A classical regression framework for mediation analysis: fitting one model to estimate mediation effects.
    Saunders CT; Blume JD
    Biostatistics; 2018 Oct; 19(4):514-528. PubMed ID: 29087439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantifying diagnostic accuracy improvement of new biomarkers for competing risk outcomes.
    Wang Z; Cheng Y; Seaberg EC; Becker JT
    Biostatistics; 2020 Feb; 23(2):666-82. PubMed ID: 33324980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SMART longitudinal analysis: A tutorial for using repeated outcome measures from SMART studies to compare adaptive interventions.
    Nahum-Shani I; Almirall D; Yap JRT; McKay JR; Lynch KG; Freiheit EA; Dziak JJ
    Psychol Methods; 2020 Feb; 25(1):1-29. PubMed ID: 31318231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient and robust approaches for analysis of sequential multiple assignment randomized trials: Illustration using the ADAPT-R trial.
    Montoya LM; Kosorok MR; Geng EH; Schwab J; Odeny TA; Petersen ML
    Biometrics; 2023 Sep; 79(3):2577-2591. PubMed ID: 36493463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On the choice of timescale for other cause mortality in a competing risk setting using flexible parametric survival models.
    Skourlis N; Crowther MJ; Andersson TM; Lambert PC
    Biom J; 2022 Oct; 64(7):1161-1177. PubMed ID: 35708221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Meta-analysis for aggregated survival data with competing risks: a parametric approach using cumulative incidence functions.
    Bonofiglio F; Beyersmann J; Schumacher M; Koller M; Schwarzer G
    Res Synth Methods; 2016 Sep; 7(3):282-93. PubMed ID: 26387882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomization, matching, and propensity scores in the design and analysis of experimental studies with measured baseline covariates.
    Loux TM
    Stat Med; 2015 Feb; 34(4):558-70. PubMed ID: 25384851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dynamic prediction of cumulative incidence functions by direct binomial regression.
    Grand MK; de Witte TJM; Putter H
    Biom J; 2018 Jul; 60(4):734-747. PubMed ID: 29577376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stagewise pseudo-value regression for time-varying effects on the cumulative incidence.
    Zöller D; Schmidtmann I; Weinmann A; Gerds TA; Binder H
    Stat Med; 2016 Mar; 35(7):1144-58. PubMed ID: 26510388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estimation in the progressive illness-death model: A nonexhaustive review.
    Meira-Machado L; Sestelo M
    Biom J; 2019 Mar; 61(2):245-263. PubMed ID: 30457674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.